SENSEX NIFTY

Drugs

Oct 22, 2014 at 19:05 | Source: Moneycontrol.com
Beryl Drugs has reported a sales total income from operations of Rs 3.33 crore and a net profit of Rs 0.15 crore for the quarter ended Sep '14
Oct 21, 2014 at 16:12 | Source: PTI
Terming the US as a high growth market for the company, the Mumbai-based firm said it aims to grow at around 25 percent in the world's largest drug market.
Oct 20, 2014 at 16:08 | Source: CNBC-TV18
The growth for the international generics, however, remain muted at about 9 percent due to higher base last year.
Oct 15, 2014 at 20:09 | Source: CNBC-TV18
NPPA had issued guidelines in May for regulating prices of non essential drugs. Subsequently, an order was passed in July for regulating prices of 108 non-essential drugs.
Oct 13, 2014 at 21:12 | Source: Moneycontrol.com
Welcure Drugs & Pharmaceuticals has informed that Shri. D C Jain has resigned from the post of Company Secretaryship with effect from October 06, 2014 and Ms. Rashi Aggarwal, a qualified member of the Institute of Company Secretaries of India has been appointed as Company Secretary of the Company.
Oct 13, 2014 at 21:11 | Source: Moneycontrol.com
Welcure Drugs & Pharmaceuticals has informed that Ms. Rashi Aggarwal has been appointed as Woman Independent director of the Company with effect from October 06, 2014.
Oct 13, 2014 at 21:11 | Source: Moneycontrol.com
Welcure Drugs & Pharmaceuticals has informed that Shri R. K. Pandey has resigned from the post of directorship of the Company with effect from September 30, 2014.
Oct 13, 2014 at 10:46 | Source: Moneycontrol.com
Suven Life Sciences drug discovery portfolio which has expanded into several new therapeutic areas such as Major Depressive Disorder (MDD), Obesity and Pain through Neuronal Nicotinic Receptor modulators resulted in the grant of one (1) product patent from USA (8735423) and one (1) product patent from South Korea (10-1410903).
Oct 09, 2014 at 16:36 | Source: CNBC-TV18
The PIL has argued that lifting the price cap with lead to windfall gains for pharma companies and that removing the price cap is unconstitutional against public interest.
Oct 09, 2014 at 13:12 | Source: Moneycontrol.com
A JM financial probe said that the probability of any major action against generic pharma companies accused of inflating generic drug prices is low because such as precedent has not taken place in the past, there is uncertainty on the extent of price increases and cartellization may be difficult to prove.
Messages on Drugs »

maximindia

Platinum Member

580 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th

Market Statistician

Platinum Member

10437 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th

News across the web »
Oct 25, 2014 at 03:15 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.